While LDL cholesterol receives much of the attention in discussions of cardiovascular risk, triglycerides provide equally important insight into metabolic health.
Persistently elevated triglycerides are often one of the earliest detectable signs of insulin resistance, frequently rising years before abnormalities appear in fasting glucose or HbA1c.
For clinicians and patients alike, triglycerides can function as an early warning signal of cardiometabolic dysfunction, reflecting how effectively the body handles carbohydrates and insulin.
Why High Triglycerides Are More Than a Fat Problem
A common misconception is that elevated triglycerides are primarily caused by eating too much dietary fat.
In reality, triglyceride levels are often more reflective of carbohydrate metabolism and insulin signaling than fat intake alone. This is why elevated triglycerides are strongly associated with insulin resistance, metabolic syndrome, and type 2 diabetes (Reaven, 1999).
Unlike LDL cholesterol, which is influenced heavily by saturated fat intake and cholesterol metabolism in the liver, triglycerides respond rapidly to blood glucose levels and insulin function
Normal Metabolism: How Triglycerides Are Supposed to Behave
Under normal metabolic conditions, carbohydrates are digested into glucose and absorbed into the bloodstream after a meal. Rising blood glucose stimulates insulin release from the pancreas. Insulin facilitates glucose uptake into muscle and adipose tissue, where it is used for energy or stored.
When insulin sensitivity is intact, glucose is efficiently cleared from circulation, insulin levels decline, and post-meal triglyceride elevations are modest and temporary. Triglyceride-rich lipoproteins are rapidly cleared and utilized by muscle tissue for energy.
Insulin Resistance: Why Triglycerides Rise First
In insulin resistance, muscle and fat cells become less responsive to insulin. Glucose uptake is impaired despite normal insulin levels. To compensate, the pancreas secretes progressively more insulin to maintain normal blood glucose levels. This state of chronic hyperinsulinemia can persist for years before diabetes is diagnosed.
While muscle and adipose tissue often become insulin resistant early, the liver typically remains insulin sensitive.
From the liver’s perspective, elevated insulin signals a fed, energy-abundant state. In response, the liver converts excess glucose into triglycerides to be stored in fat tissue. These triglycerides are packaged into very-low-density lipoprotein (VLDL) particles and released into circulation, increasing triglyceride-rich particles in the blood (Parks & Hellerstein, 2000; Horton et al., 2002).
During this early phase, triglycerides often rise before glucose or HbA1c, making them a sensitive early marker of impaired insulin action (Reaven, 1999).
Impaired Triglyceride Clearance Worsens the Problem
Under healthy conditions, insulin activates lipoprotein lipase, an enzyme that removes triglycerides from circulating VLDL and allows uptake into adipose tissue.
However, in insulin-resistant fat tissue, lipoprotein lipase activity is reduced. This impaired clearance allows triglyceride-rich particles to remain in circulation longer, further elevating fasting triglyceride levels (Adiels et al., 2008).
Atherogenic Dyslipidemia: The High-Risk Lipid Pattern
The combination of increased hepatic triglyceride production and impaired clearance leads to atherogenic dyslipidemia, a lipid pattern commonly seen in insulin resistance.
This pattern typically includes:
- Elevated triglycerides
- Low HDL cholesterol
- Increased small, dense LDL particles
Triglyceride-rich VLDL remnants and small LDL particles are particularly atherogenic, helping explain why elevated triglycerides are associated with cardiovascular risk even when LDL-C appears normal (Adiels et al., 2008).
Why Carbohydrates Matter More for Triglyceride Reduction
Because this pathway is driven by glucose and insulin signaling, carbohydrate intake becomes one of the most powerful modifiable drivers of triglycerides.
Controlled feeding studies consistently show that reducing refined carbohydrates and added sugars leads to rapid and clinically meaningful reductions in triglycerides, often within weeks.
Importantly, these improvements frequently occur independent of weight loss, suggesting that triglyceride reductions reflect improved metabolic function rather than calorie restriction alone (Parks & Hellerstein, 2000; Volek et al., 2004).
Practical Nutrition Strategies for High Triglycerides
For individuals with elevated triglycerides, the goal is not carbohydrate elimination but carbohydrate optimization. This includes:
- Reducing sugar-sweetened beverages
- Limiting refined grains
- Avoiding frequent snacking
- Prioritizing protein at meals
- Pairing carbohydrates with fiber and healthy fats
These changes lower insulin demand, reduce hepatic triglyceride production, and improve triglyceride clearance. As insulin levels decline, VLDL output decreases and the lipid profile shifts toward a less atherogenic pattern.
Triglycerides as a Metabolic Report Card
Triglycerides function as a real-time metabolic report card. When levels are elevated, they often reflect excessive insulin signaling and impaired carbohydrate handling.
When triglycerides fall in response to dietary and lifestyle interventions, it is a strong indication that insulin sensitivity is improving, often before changes appear in glucose or cholesterol markers. For this reason, triglycerides remain one of the most actionable and responsive biomarkers in cardiometabolic nutrition.
About the Author
Joseph Lehrberg, MS, RD is a registered dietitian specializing in cardiovascular and metabolic health and founder of CardioFunction Integrative Nutrition Services, a nutrition practice based in Boston. He works with patients with elevated cholesterol, high coronary artery calcium scores, high triglycerides, statin intolerance, and other cardiometabolic risk factors to develop evidence-based nutrition strategies for long-term heart health.
Learn more about working with him here.
References
Reaven GM. Insulin resistance and its consequences: type 2 diabetes mellitus and coronary heart disease. Diabetes Care. 1999;22(3):368–374.
Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28(7):1225–1236.
Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–1131.
Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000;71(2):412–433.
Volek JS, Sharman MJ, Gómez AL, et al. Comparison of a very low-carbohydrate and low-fat diet on fasting lipids, LDL subclasses, insulin resistance, and postprandial lipemic responses in overweight women. J Am Coll Nutr. 2004;23(2):177–184.
